ADMA Biologics Inc (ADMA) Insider Trading
- $38,371,256.48
- $47,915,808.35
- Sept. 9, 2024
- Adam S Grossman
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 9, 2024 | Director | 9,000 | $18.47 | Sell | $166,230.00 | |
Aug. 30, 2024 | COO | 24,150 | $16.90 | Sell | $408,135.00 | |
Aug. 29, 2024 | Director | 136,861 | $17.27 | Sell | $2,363,589.47 | |
Aug. 26, 2024 | CEO | 236,889 | $17.69 | Sell | $4,190,566.41 | |
Aug. 23, 2024 | Director | 60,000 | $18.26 | Sell | $1,095,600.00 | |
June 14, 2024 | CEO | 100,000 | $10.72 | Sell | $1,072,000.00 | |
March 18, 2024 | Director | 49,887 | $6.01 | Sell | $299,820.87 | |
March 15, 2024 | Director | 183,008 | $6.01 | Sell | $1,099,878.08 | |
March 13, 2024 | Director | 407,000 | $6.21 | Sell | $2,527,470.00 | |
Aug. 30, 2023 | Director | 130,000 | $3.71 | Buy | $482,300.00 | |
Aug. 24, 2023 | Director | 25,000 | $3.90 | Buy | $97,500.00 | |
Aug. 22, 2023 | Director | 1,433,304 | $3.87 | Sell | $5,546,886.48 | |
Aug. 18, 2023 | CEO | 250,000 | $4.15 | Sell | $1,037,500.00 | |
Aug. 15, 2023 | CEO | 510,469 | $4.54 | Sell | $2,317,529.26 | |
Aug. 15, 2023 | CFO | 211,578 | $4.60 | Sell | $973,258.80 | |
Dec. 9, 2022 | CEO | 14,983 | $2.86 | Buy | $42,851.38 | |
Dec. 9, 2022 | CFO | 6,993 | $2.86 | Buy | $19,999.98 | |
Oct. 25, 2021 | CEO | 250,000 | $1.00 | Buy | $250,000.00 | |
Oct. 25, 2021 | CFO | 30,000 | $1.00 | Buy | $30,000.00 | |
Oct. 25, 2021 | Director | 100,000 | $1.00 | Buy | $100,000.00 | |
Sept. 29, 2021 | Major Shareholder | 82,505 | $1.16 | Sell | $95,705.80 | |
Sept. 27, 2021 | Major Shareholder | 250,000 | $1.23 | Sell | $307,500.00 | |
Sept. 23, 2021 | Major Shareholder | 780,000 | $1.27 | Sell | $990,600.00 | |
Aug. 19, 2021 | Major Shareholder | 350,352 | $1.24 | Sell | $434,436.48 | |
Aug. 17, 2021 | Major Shareholder | 879,092 | $1.35 | Sell | $1,186,774.20 | |
Sept. 10, 2020 | Director | 5,000 | $2.22 | Buy | $11,100.00 | |
Sept. 10, 2020 | Director | 5,000 | $2.22 | Buy | $11,100.00 | |
Sept. 8, 2020 | CMO | 4,000 | $2.20 | Buy | $8,800.00 | |
Aug. 21, 2020 | Director | 5,300 | $2.56 | Buy | $13,568.00 | |
Aug. 12, 2020 | Director | 10,200 | $2.89 | Buy | $29,478.00 | |
Aug. 11, 2020 | CFO | 4,000 | $2.97 | Buy | $11,880.00 | |
Aug. 10, 2020 | CMO | 7,000 | $2.88 | Buy | $20,160.00 | |
Aug. 10, 2020 | CEO | 5,000 | $3.06 | Buy | $15,300.00 | |
March 19, 2020 | Major Shareholder | 500,000 | $2.10 | Buy | $1,050,000.00 | |
Feb. 11, 2020 | CEO | 28,571 | $3.50 | Buy | $99,998.50 | |
Feb. 11, 2020 | CFO | 7,142 | $3.50 | Buy | $24,997.00 | |
Feb. 11, 2020 | CMO | 4,285 | $3.50 | Buy | $14,997.50 | |
Feb. 11, 2020 | Director | 20,000 | $3.50 | Buy | $70,000.00 | |
Feb. 11, 2020 | Major Shareholder | 4,563,700 | $3.50 | Buy | $15,972,950.00 | |
June 6, 2019 | Major Shareholder | 5,813,954 | $3.75 | Sell | $21,802,327.50 | |
May 21, 2019 | Major Shareholder | 4,000,000 | $4.00 | Buy | $16,000,000.00 | |
May 17, 2019 | Director | 25,000 | $4.00 | Buy | $100,000.00 | |
May 17, 2019 | EVP | 4,500 | $4.00 | Buy | $18,000.00 | |
May 17, 2019 | CFO | 5,000 | $4.00 | Buy | $20,000.00 | |
May 17, 2019 | Insider | 30,000 | $4.00 | Buy | $120,000.00 | |
June 8, 2018 | CFO | 5,000 | $4.78 | Buy | $23,900.00 | |
June 8, 2018 | Director | 20,921 | $4.78 | Buy | $100,002.38 | |
June 8, 2018 | CEO | 52,301 | $4.78 | Buy | $249,998.78 | |
Nov. 9, 2017 | CMO | 10,000 | $2.15 | Buy | $21,500.00 | |
Nov. 9, 2017 | Insider | 485,000 | $2.15 | Buy | $1,042,750.00 |
Insiders are both buying and selling ADMA Biologics Inc stock.
The insider traders at ADMA Biologics Inc are: Adam S Grossman, Brian Lenz, Jerrold B Grossman, James Mond, Perceptive Advisors Llc, Lawrence P Guiheen, Jerrold B. Grossman, Steve Elms, Young Kwon, Adam S. Grossman, Eric I Richman, Biotest Divestiture Trust, Kaitlin M Kestenberg-Messina, Life Sciences Maste Perceptive, and Bryant Fong
The most active insider trader at ADMA Biologics Inc is Adam S Grossman with 24 trades.
Biotest Divestiture Trust has sold the most ADMA Biologics Inc stock with a total value of $43,604,655.00.
Life Sciences Maste Perceptive has bought the most ADMA Biologics Inc stock with a total value of $32,000,000.00.
The most recent insider trade for ADMA Biologics Inc was on Sept. 9, 2024.
The single biggest insider buy for ADMA Biologics Inc was from Life Sciences Maste Perceptive with a total value of $16,000,000.00 on May 21, 2019.
The single biggest insider sell for ADMA Biologics Inc was from Biotest Divestiture Trust with a total value of $21,802,327.50 on June 6, 2019.